What is Sichuan Kelun-Biotech Biopharmaceutical Co Enterprise Value?
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Sichuan Kelun-Biotech Biopharmaceutical Co Enterprise Value Chart
Sichuan Kelun-Biotech Biopharmaceutical Co Annual Data
Trend
Dec21
Dec22
Dec23
Enterprise Value
-
-
19,855.26
Sichuan Kelun-Biotech Biopharmaceutical Co Quarterly Data
Competitive Comparison of Sichuan Kelun-Biotech Biopharmaceutical Co's Enterprise Value
For the Biotechnology subindustry, Sichuan Kelun-Biotech Biopharmaceutical Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sichuan Kelun-Biotech Biopharmaceutical Co's Enterprise Value Distribution in the Biotechnology Industry
* The bar in red indicates where Sichuan Kelun-Biotech Biopharmaceutical Co's Enterprise Value falls into.
Sichuan Kelun-Biotech Biopharmaceutical Co Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sichuan Kelun-Biotech Biopharmaceutical Co (HKSE:06990) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Sichuan Kelun-Biotech Biopharmaceutical Co's EV-to-EBIT for today is
Sichuan Kelun-Biotech Biopharmaceutical Co's current Enterprise Value is HK$34,485.4 Mil.
Sichuan Kelun-Biotech Biopharmaceutical Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$-273.3 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Sichuan Kelun-Biotech Biopharmaceutical Co's EV-to-EBITDA for today is:
Sichuan Kelun-Biotech Biopharmaceutical Co's current Enterprise Value is HK$34,485.4 Mil.
Sichuan Kelun-Biotech Biopharmaceutical Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$-252.6 Mil.
Sichuan Kelun-Biotech Biopharmaceutical Co's current Enterprise Value is HK$34,485.4 Mil.
Sichuan Kelun-Biotech Biopharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$512.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sichuan Kelun-Biotech Biopharmaceutical Co Enterprise Value Related Terms
Thank you for viewing the detailed overview of Sichuan Kelun-Biotech Biopharmaceutical Co's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Sichuan Kelun-Biotech Biopharmaceutical Co (HKSE:06990) Business Description
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is an innovative biopharmaceutical company committed to the R&D, manufacturing and commercialization of novel drugs to address medical needs in China and globally. It is one of the first movers in the development of antibody-drug conjugates (ADCs), with over a decade of accumulated experience in ADC development. The company takes a systematic, indication-oriented approach to target the world's prevalent or hard-to-treat cancers, and other diseases and conditions affecting a large and underserved population.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:06990 has been successfully added to your